logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Dongguang Qin

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: University of Michigan. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongguang Qin. Retrieved from https://idiyas.com/inventor/dongguang-qin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 28.6



Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 138(Granted Patents)


Location History:

  • Auburn Hills, MI (US) (2010 - 2012)
  • Ann Arbor, MI (US) (2010 - 2014)

Company Filing History:

goldMedal7 out of 3,536 
 
University of Michigan
 patents

Years Active: 2010-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 8901117 - Small molecule inhibitors of MDM2 and the uses thereof (2014-12-02),
2. 8222288 - Small molecule inhibitors of MDM2 and the uses thereof (2012-07-17),
3. 8202902 - Bivalent SMAC mimetics and the uses thereof (2012-06-19),
4. 8088931 - Small molecule inhibitors of MDM2 and the uses thereof (2012-01-03),
5. 7960372 - Bivalent Smac mimetics and the uses thereof (2011-06-14),
6. 7759383 - Small molecule inhibitors of MDM2 and the uses thereof (2010-07-20),
7. 7737174 - Indole inhibitors of MDM2 and the uses thereof (2010-06-15),

Title: The Innovative Contributions of Dongguang Qin

Introduction

Dongguang Qin is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of molecular biology, particularly in the development of small molecule inhibitors. With a total of 7 patents to his name, Qin's work has the potential to impact cancer treatment and cell growth regulation.

Latest Patents

One of his latest patents focuses on small molecule inhibitors of MDM2 and their uses. This invention relates to small molecules that inhibit the interaction between p53 and MDM2. The compounds developed by Qin can be utilized for inhibiting cell growth, inducing cell death, inducing cell cycle arrest, and sensitizing cells to additional agents. This innovative approach offers new avenues for therapeutic interventions in cancer treatment.

Career Highlights

Dongguang Qin is affiliated with the University of Michigan, where he conducts his research and development. His work is characterized by a commitment to advancing scientific knowledge and improving health outcomes through innovative solutions.

Collaborations

Qin has collaborated with notable colleagues such as Shaomeng Wang and Zaneta Nikolovska-Coleska. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Dongguang Qin's contributions to the field of molecular biology and his innovative patents position him as a key figure in the ongoing fight against cancer. His work exemplifies the importance of research and collaboration in developing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…